{"pub": "telegraph", "url": "https://telegraph.co.uk/investing/funds/stocks-will-cost-woodford-investors-money", "downloaded_at": "2019-10-17 08:05:57.193997+00:00", "title": "The stocks that will cost Woodford investors the most money", "language": "en", "text": "Neil Woodford's investments in logistics firm Eddie Stobart, pharmaceutical company Tissue Regenix and intellectual property business Allied Minds could contribute huge losses to beleaguered investors, as the Equity Income fund's stakes are too large to sell at a profit.\n\nFollowing the sacking of Neil Woodford from his flagship fund, the fate of a number of companies in which he held a significant stake are now up in the air.\n\nLink, the fund administrator, has appointed BlackRock to sell the portion of the fund invested in listed British companies. However, it could face difficulties given Mr Woodford's penchant for buying up large stakes in stocks.\n\nThe fund owns more than 5pc in 18 companies listed...", "description": "Neil Woodford's investments in logistics firm Eddie Stobart, pharmaceutical company Tissue Regenix and intellectual property business Allied Minds could contribute huge losses to beleaguered investors, as the Equity Income fund's stakes are too large to sell at a profit.", "authors": ["Jonathan Jones", "Taha Lokhandwala", "Katie Morley"], "top_image": "https://www.telegraph.co.uk/content/dam/investing/2019/10/03/MONEY-SERIES-01-xlarge_trans_NvBQzQNjv4BqxnlSljj15z1o8iKqMGA7tyH0-jRUT4rHK8EgtaGoQwQ.jpg?imwidth=1200", "published_at": "2019-10-03"}